Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | FOS | P01100 | 1/20 | 0.42 |
| ▸ | TTR | P02766 | 1/20 | 0.42 |
| ▸ | JUN | P05412 | 1/20 | 0.42 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.42 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.42 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30147378 | 1.00 | CA2 (0.47) | CA2GAAMAPTTSHRMAPK1 | |
| SCHEMBL11842974 | 0.90 | CA2 (0.61) | CA2GAAMAPTTSHRMAPK1 | |
| SCHEMBL7470025 | 0.86 | KDM4E (0.46) | CA2GAAMAPTTSHRMAPK1 | |
| SCHEMBL1587262 | 0.86 | PDCD1 (0.47) | CA2GAAMAPTTSHRMAPK1 | |
| SCHEMBL465122 | 0.85 | GABRA1 (0.46) | TSHRMAPK1ALDH1A1KDM4EATM | |
| SCHEMBL10052083 | 0.83 | CA2 (0.47) | CA2GAAALDH1A1KDM4EATM | |
| SCHEMBL1080853 | 0.83 | CA2 (0.68) | CA2MAPTALDH1A1KDM4EATM | |
| SCHEMBL29559892 | 0.83 | CA2 (0.68) | CA2MAPTALDH1A1KDM4EATM | |
| SCHEMBL6228438 | 0.82 | PIK3CD (0.41) | CA2GAAMAPTTSHRMAPK1 | |
| SCHEMBL11853519 | 0.81 | TSHR (0.48) | GAAMAPTTSHRMAPK1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0714557-B1 | METHOD OF PROVIDING A FILM OF CONJUGATED, SUBSTITUTED OR UNSUBSTITUTED POLY(P-PHENYLENE VINYLENE) ON A SUBSTRATE BY CHEMICAL VAPOUR DEPOSITION (CVD), AS WELL AS A METHOD OF MANUFACTURING AN ELECTROLUMINESCENT (EL) DEVICE | KONINKL PHILIPS ELECTRONICS NV (NL) | 1998-11-25 | — | — | EP | claimed |
| US-5670212-A | CVD method of providing a film of conjugated, substituted or unsubstituted poly(p-phenylene vinylene) on a substrate | U.S. PHILIPS CORPORATION (US) | 1997-09-23 | — | — | US | claimed |
| US-20230160904-A1 | REAGENT FOR MASS SPECTROMETRY | ROCHE DIAGNOSTICS OPERATIONS, INC. | 2023-05-25 | — | — | US | disclosed |
| US-20230160904-A1 | REAGENT FOR MASS SPECTROMETRY | ROCHE DIAGNOSTICS OPERATIONS, INC. | 2023-05-25 | — | — | US | disclosed |
| EP-4154009-A1 | REAGENT FOR MASS SPECTROMETRY | F. Hoffmann-La Roche AG (CH) | 2023-03-29 | — | — | EP | disclosed |
| WO-2021233997-A1 | REAGENT FOR MASS SPECTROMETRY | F. HOFFMANN-LA ROCHE AG (CH) | 2021-11-25 | — | — | WO | disclosed |
| EP-2437792-B1 | IMAGING OF MYELIN BASIC PROTEIN | GEN ELECTRIC (US) | 2015-10-21 | — | — | EP | disclosed |
| US-8617515-B2 | Imaging of myelin basic protein | GENERAL ELECTRIC COMPANY (US) | 2013-12-31 | — | — | US | disclosed |
| WO-2012054695-A1 | NTIMICROBIAL AMPHIPHILES AND METHODS FOR THEIR USE | JAMES MADISON INNOVATIONS, INC. (US) | 2012-04-26 | — | — | WO | disclosed |
| US-20100310457-A1 | IMAGING OF MYELIN BASIC PROTEIN | GENERAL ELECTRIC COMPANY (US) | 2010-12-09 | — | — | US | disclosed |
| US-20100310457-A1 | IMAGING OF MYELIN BASIC PROTEIN | GENERAL ELECTRIC COMPANY (US) | 2010-12-09 | — | — | US | disclosed |
| US-20100310457-A1 | IMAGING OF MYELIN BASIC PROTEIN | GENERAL ELECTRIC COMPANY (US) | 2010-12-09 | — | — | US | disclosed |
| EP-0714557-B1 | METHOD OF PROVIDING A FILM OF CONJUGATED, SUBSTITUTED OR UNSUBSTITUTED POLY(P-PHENYLENE VINYLENE) ON A SUBSTRATE BY CHEMICAL VAPOUR DEPOSITION (CVD), AS WELL AS A METHOD OF MANUFACTURING AN ELECTROLUMINESCENT (EL) DEVICE | KONINKL PHILIPS ELECTRONICS NV (NL) | 1998-11-25 | — | — | EP | disclosed |
| US-5670212-A | CVD method of providing a film of conjugated, substituted or unsubstituted poly(p-phenylene vinylene) on a substrate | U.S. PHILIPS CORPORATION (US) | 1997-09-23 | — | — | US | disclosed |
| EP-0714557-A1 | METHOD OF PROVIDING A FILM OF CONJUGATED, SUBSTITUTED OR UNSUBSTITUTED POLY(P-PHENYLENE VINYLENE) ON A SUBSTRATE BY CHEMICAL VAPOUR DEPOSITION (CVD), AS WELL AS A METHOD OF MANUFACTURING AN ELECTROLUMINESCENT (EL) DEVICE | Koninklijke Philips Electronics N.V. (NL) | 1996-06-05 | — | — | EP | disclosed |
| WO-1995031831-A1 | METHOD OF PROVIDING A FILM OF CONJUGATED, SUBSTITUTED OR UNSUBSTITUTED POLY(P-PHENYLENE VINYLENE) ON A SUBSTRATE BY CHEMICAL VAPOUR DEPOSITION (CVD), AS WELL AS A METHOD OF MANUFACTURING AN ELECTROLUMINESCENT (EL) DEVICE | PHILIPS ELECTRONICS N.V. (NL) | 1995-11-23 | — | — | WO | disclosed |
| US-5312913-A | Complexes of electron donors and electron acceptors | IDEMITSU KOSAN CO., LTD. (JP) | 1994-05-17 | — | — | US | disclosed |
| US-5175280-A | Electroconductive complexes; heat resistance | IDEMITSU KOSAN CO., LTD. (JP) | 1992-12-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100310457-A1 | IMAGING OF MYELIN BASIC PROTEIN | MAG, PMP22, MYT1 | CA2 3576/4885GAA 3352/4885MAPT 1129/4885 |
| US-20230160904-A1 | REAGENT FOR MASS SPECTROMETRY | SRMS, AKR7A2, PTMS | CA2 1051/4885GAA 533/4885MAPT 3634/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.